Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin Ocular Implant in Cataract Surgery
NCT04682288Phase 1Completed
- Sponsor
- PolyActiva
- Start
- Jan 2021
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 1, open-label, single-arm trial of levofloxacin in cataract, sponsored by PolyActiva. Primary endpoints: Ocular Inflammation at 90 days, Endothelial Cell Density at 90 days and 1 more. Started Jan 2021; status: completed.
02
Drugs
levofloxacin
03
Conditions
cataract
Beyond the preview
Go deeper on NCT04682288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04682288.